Cytochrome P450 monooxygenases oxidize a large variety of nutritive and non-nutritive lipids including man-made xenobiotics. P450 oxidation often provides the first step in the elimination of troublesome environmental compounds but can also produce teratogenic, toxic or carcinogenic products and generate reactive oxygen species. Conditional regulation of P450 expression can alter the balance between toxication and detoxication of xenobiotics. The expression of individual P450 enzymes is controlled by a variety of hormonal and metabolic inputs as well as by xenobiotics. Current projects focus on the regulation and structure of the human family 4 P450 (CYP4) enzymes. CYP4 enzymes oxidize both endobiotic and xenobiotic substrates and contribute to lipid homeostasis, protection from xenobiotics, and signal transduction pathways regulating hemodynamics and inflammation. Although the regulation of CYP4 gene expression has been characterized in various species, significant differences are evident between species in the number of CYP4 genes and the pathways that regulate them. The unique features of the human CYP4 family need to be identified, and the regulation and function of these enzymes should be evaluated in complex physiologic settings. The proposed studies address mechanisms of human CYP4 gene regulation through the identification of cis-acting control elements and the associated transcription factors that regulate expression of the CYP4A11, CYP4F2 and CYP4Z1 genes in response to xenobiotics, hormones and nutritional status. CYP4A11 and CYP4Z1 transgenic mice will be generated in order to characterize regulatory responses to physiologic alterations that accompany conditions such as pregnancy and fasting. In addition, techniques developed in our laboratory will be applied to the modification, expression and crystallization of representative CYP4 enzymes to identify structural determinants of substrate specificity and their unique capacity to selectively oxidize primary carbon hydrogen bonds. ? ? ?

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
5R01HD004445-36
Application #
7106479
Study Section
Xenobiotic and Nutrient Disposition and Action Study Section (XNDA)
Program Officer
Ilekis, John V
Project Start
1978-09-29
Project End
2010-05-31
Budget Start
2006-06-01
Budget End
2007-05-31
Support Year
36
Fiscal Year
2006
Total Cost
$367,601
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
781613492
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Albertolle, Matthew E; Kim, Donghak; Nagy, Leslie D et al. (2017) Heme-thiolate sulfenylation of human cytochrome P450 4A11 functions as a redox switch for catalytic inhibition. J Biol Chem 292:11230-11242
Savas, Üzen; Wei, Shouzou; Hsu, Mei-Hui et al. (2016) 20-Hydroxyeicosatetraenoic Acid (HETE)-dependent Hypertension in Human Cytochrome P450 (CYP) 4A11 Transgenic Mice: NORMALIZATION OF BLOOD PRESSURE BY SODIUM RESTRICTION, HYDROCHLOROTHIAZIDE, OR BLOCKADE OF THE TYPE 1 ANGIOTENSIN II RECEPTOR. J Biol Chem 291:16904-19
Bumpus, Namandjé N; Johnson, Eric F (2011) 5-Aminoimidazole-4-carboxyamide-ribonucleoside (AICAR)-stimulated hepatic expression of Cyp4a10, Cyp4a14, Cyp4a31, and other peroxisome proliferator-activated receptor ?-responsive mouse genes is AICAR 5'-monophosphate-dependent and AMP-activated protein J Pharmacol Exp Ther 339:886-95
Hsu, Mei-Hui; Savas, Uzen; Lasker, Jerome M et al. (2011) Genistein, resveratrol, and 5-aminoimidazole-4-carboxamide-1-?-D-ribofuranoside induce cytochrome P450 4F2 expression through an AMP-activated protein kinase-dependent pathway. J Pharmacol Exp Ther 337:125-36
Savas, Uzen; Machemer, Daniel E W; Hsu, Mei-Hui et al. (2009) Opposing roles of peroxisome proliferator-activated receptor alpha and growth hormone in the regulation of CYP4A11 expression in a transgenic mouse model. J Biol Chem 284:16541-52
Hsu, Mei-Hui; Savas, Uzen; Griffin, Keith J et al. (2007) Human cytochrome p450 family 4 enzymes: function, genetic variation and regulation. Drug Metab Rev 39:515-38
Hsu, Mei-Hui; Savas, Uzen; Griffin, Keith J et al. (2007) Regulation of human cytochrome P450 4F2 expression by sterol regulatory element-binding protein and lovastatin. J Biol Chem 282:5225-36
Savas, Uzen; Hsu, Mei-Hui; Griffin, Keith J et al. (2005) Conditional regulation of the human CYP4X1 and CYP4Z1 genes. Arch Biochem Biophys 436:377-85
Savas, Uzen; Hsu, Mei-Hui; Johnson, Eric F (2003) Differential regulation of human CYP4A genes by peroxisome proliferators and dexamethasone. Arch Biochem Biophys 409:212-20
Cowart, L Ashley; Wei, Shouzuo; Hsu, Mei-Hui et al. (2002) The CYP4A isoforms hydroxylate epoxyeicosatrienoic acids to form high affinity peroxisome proliferator-activated receptor ligands. J Biol Chem 277:35105-12

Showing the most recent 10 out of 41 publications